Biotechnology News EMSAM Search

| Biotechnology feed | All feeds

BioNews
Biotechnology, Pharmaceutical and Life Science News

Search Results

Documents 1-25 out of 32 found

Current Search: emsam: 32

KV Pharmaceutical Signs Licensing Agreement With Gedeon Richter
The agreement provides Gedeon Richter to manufacture and distribute KV proprietary technologies and products Related News Transaction expected to close in the second half of 2009 ...

Dey, a subsidiary of Mylan, is all set to market and...

Pharmaceutical Business Review: Jun 23 2009 10:15AM
Matching: emsam

Find similar documents

Dey L.P. to Market EMSAM(R) Skin Patch for Treatment of Major Depressive Disorder
- (NewsRx.com) -- Dey L.P., a subsidiary of Mylan Inc.

(NASDAQ:MYL), announced that it has begun to market and distribute EMSAM(R) in the U.S.

EMSAM, a selegiline transdermal system, is a monoamine oxidase inhibitor (MAOI), which...

Pharmacy Choice: Jun 10 2009 2:59AM
Matching: emsam

Find similar documents

Dey L.P. to Market EMSAM Skin Patch for Treatment of Major Depressive Disorder
PITTSBURGH, May 29 /PRNewswire-FirstCall/ -- Dey L.P., a subsidiary of Mylan Inc.

(NASDAQ:MYL) , today announced that it has begun to market and distribute EMSAM(R) in the U.S.

EMSAM, a selegiline transdermal system, is a monoamine...

Drugs.com: Jun 2 2009 3:24AM
Matching: emsam

Find similar documents

Dey initiates marketing of Emsam skin patch in US
(Datamonitor via COMTEX) -- Dey, a specialty pharmaceutical company, and a subsidiary of Mylan, has started to market and distribute Emsam in the US.

Emsam was previously marketed and distributed by Bristol-Myers Squibb through...

Therapeutics Daily: Jun 2 2009 12:21PM
Matching: emsam

Find similar documents

Dey L.P. to Market EMSAM Skin Patch for Treatment of Major Depressive Disorder
(Click the title below to leave the MDLinx Network and go to the Journal's Website) Mylan, 06/01/09 Print Save in My Library Free Abstract Dey L.P., a subsidiary of Mylan Inc.

, announced that it has begun to market and distribute EMSAM...

MDLinx: Jun 1 2009 3:49PM
Matching: emsam

Find similar documents

Dey To Market Emsam Skin Patch In US
Dey, a subsidiary of Mylan, is all set to market and distribute Emsam in the US.

FDA approved EMSAM, a selegiline transdermal system, is a monoamine oxidase inhibitor for the treatment of major depressive disorder.

Related...

Pharmaceutical Business Review: May 30 2009 3:27AM
Matching: emsam

Find similar documents

Dey L.P. to Market EMSAM(R) Skin Patch for Treatment of Major Depressive Disorder
PITTSBURGH, May 29 /PRNewswire-FirstCall/ -- Dey L.P., a subsidiary of Mylan Inc.

(Nasdaq: MYL - News), today announced that it has begun to market and distribute EMSAM in the U.S.

EMSAM, a selegiline transdermal system, is a...

PR Newswire via Yahoo!: May 29 2009 11:36AM
Matching: emsam

Find similar documents

Dey L.P. to Market EMSAM(R) Skin Patch for Treatment of Major Depressive Disorder
PITTSBURGH, May 29 /PRNewswire-FirstCall/ -- Dey L.P., a subsidiary of Mylan Inc.

(Nasdaq: MYL - News), today announced that it has begun to market and distribute EMSAM in the U.S.

EMSAM, a selegiline transdermal system, is a...

Yahoo! Canada: May 29 2009 11:33AM
Matching: emsam

Find similar documents

Dey L.P. to Market EMSAM(R) Skin Patch for Treatment of Major Depressive Disorder
PITTSBURGH, May 29 /PRNewswire-FirstCall/ -- Dey L.P., a subsidiary of Mylan Inc.

, today announced that it has begun to market and distribute EMSAM(R) in the U.S.

EMSAM, a selegiline transdermal system, is a monoamine oxidase...

KOTA Territory News: May 29 2009 8:33PM
Matching: emsam

Find similar documents

Dey L.P. to Market EMSAM(R) Skin Patch for Treatment of Major Depressive Disorder
PITTSBURGH, May 29 /PRNewswire-FirstCall/ -- Dey L.P., a subsidiary of Mylan Inc.

, today announced that it has begun to market and distribute EMSAM(R) in the U.S.

EMSAM, a selegiline transdermal system, is a monoamine oxidase...

TickerTech.com: May 29 2009 8:26PM
Matching: emsam

Find similar documents

Dey L.P. to Market EMSAM(R) Skin Patch for Treatment of Major Depressive Disorder
Dey L.P., a subsidiary of Mylan Inc.

, today announced that it has begun to market and distribute EMSAM(R) in the U.S.

EMSAM, a selegiline transdermal system, is a monoamine oxidase inhibitor (MAOI), which was approved by the U.S....

Kait 8: May 29 2009 4:37PM
Matching: emsam

Find similar documents

Dey L.P. to Market EMSAM(R) Skin Patch for Treatment of Major Depressive Disorder
PITTSBURGH, May 29 /PRNewswire-FirstCall/ -- Dey L.P., a subsidiary of Mylan Inc.

, today announced that it has begun to market and distribute EMSAM(R) in the U.S.

EMSAM, a selegiline transdermal system, is a monoamine oxidase...

KSLA: May 29 2009 2:37PM
Matching: emsam

Find similar documents

Dey L.P. to Market EMSAM(R) Skin Patch for Treatment of Major Depressive Disorder
Dey L.P., a subsidiary of Mylan Inc.

(Nasdaq: MYL), today announced that it has begun to market and distribute EMSAM(R) in the U.S.

EMSAM, a selegiline transdermal system, is a monoamine oxidase inhibitor (MAOI), which was approved...

Phoenix Business Journal: May 29 2009 11:54AM
Matching: emsam

Find similar documents

Dey L.P. to Market EMSAM(R) Skin Patch for Treatment of Major Depressive Disorder
Dey L.P., a subsidiary of Mylan Inc.

(Nasdaq: MYL), today announced that it has begun to market and distribute EMSAM(R) in the U.S.

EMSAM, a selegiline transdermal system, is a monoamine oxidase inhibitor (MAOI), which was approved...

San Antonio Business Journal: May 29 2009 11:53AM
Matching: emsam

Find similar documents

Dey L.P. to Market EMSAM(R) Skin Patch for Treatment of Major Depressive Disorder
PITTSBURGH, May 29 /PRNewswire-FirstCall/ -- Dey L.P., a subsidiary of Mylan Inc.

(Nasdaq: MYL), today announced that it has begun to market and distribute EMSAM(R) in the U.S.

EMSAM, a selegiline transdermal system, is a monoamine...

Business Journal of Milwaukee: May 29 2009 11:51AM
Matching: emsam

Find similar documents

Dey L.P. to Market EMSAM(R) Skin Patch for Treatment of Major Depressive Disorder
PITTSBURGH, May 29 /PRNewswire-FirstCall/ -- Dey L.P., a subsidiary of Mylan Inc.

(Nasdaq: MYL), today announced that it has begun to market and distribute EMSAM(R) in the U.S.

EMSAM, a selegiline transdermal system, is a monoamine...

Cincinnati Business Journal: May 29 2009 11:50AM
Matching: emsam

Find similar documents

Dey L.P. to Market EMSAM(R) Skin Patch for Treatment of Major Depressive Disorder
PITTSBURGH, May 29 /PRNewswire-FirstCall/ -- Dey L.P., a subsidiary of Mylan Inc.

(Nasdaq: MYL), today announced that it has begun to market and distribute EMSAM(R) in the U.S.

EMSAM, a selegiline transdermal system, is a monoamine...

Columbus Business First: May 29 2009 11:50AM
Matching: emsam

Find similar documents

Dey L.P. to Market EMSAM(R) Skin Patch for Treatment of Major Depressive Disorder
PITTSBURGH, May 29 /PRNewswire-FirstCall/ -- Dey L.P., a subsidiary of Mylan Inc.

(Nasdaq: MYL), today announced that it has begun to market and distribute EMSAM(R) in the U.S.

EMSAM, a selegiline transdermal system, is a monoamine...

Atlanta Business Chronicle: May 29 2009 11:49AM
Matching: emsam

Find similar documents

Dey L.P. to Market EMSAM(R) Skin Patch for Treatment of Major Depressive Disorder
PITTSBURGH, May 29 /PRNewswire-FirstCall/ -- Dey L.P., a subsidiary of Mylan Inc.

(Nasdaq: MYL), today announced that it has begun to market and distribute EMSAM(R) in the U.S.

EMSAM, a selegiline transdermal system, is a monoamine...

Nashville Business Journal: May 29 2009 11:48AM
Matching: emsam

Find similar documents

Dey L.P. to Market EMSAM(R) Skin Patch for Treatment of Major Depressive Disorder
PITTSBURGH, May 29 /PRNewswire-FirstCall/ -- Dey L.P., a subsidiary of Mylan Inc.

(MYL), today announced that it has begun to market and distribute EMSAM(R) in the U.S.

EMSAM, a selegiline transdermal system, is a monoamine oxidase...

Houston Chronicle: May 29 2009 11:47AM
Matching: emsam

Find similar documents

Dey L.P. to Market EMSAM(R) Skin Patch for Treatment of Major Depressive Disorder
PITTSBURGH, May 29 /PRNewswire-FirstCall/ -- Dey L.P., a subsidiary of Mylan Inc.

(Nasdaq: MYL), today announced that it has begun to market and distribute EMSAM(R) in the U.S.

EMSAM, a selegiline transdermal system, is a monoamine...

Portland Business Journal: May 29 2009 11:45AM
Matching: emsam

Find similar documents

Dey L.P. to Market EMSAM(R) Skin Patch for Treatment of Major Depressive Disorder
PITTSBURGH, May 29 /PRNewswire-FirstCall/ -- Dey L.P., a subsidiary of Mylan Inc.

, today announced that it has begun to market and distribute EMSAM(R) in the U.S.

EMSAM, a selegiline transdermal system, is a monoamine oxidase...

FinanzNachrichten.de: May 29 2009 11:44AM
Matching: emsam

Find similar documents

Dey L.P. to Market EMSAM(R) Skin Patch for Treatment of Major Depressive Disorder
PITTSBURGH, May 29 /PRNewswire-FirstCall/ -- Dey L.P., a subsidiary of Mylan Inc.

(Nasdaq: MYL), today announced that it has begun to market and distribute EMSAM(R) in the U.S.

EMSAM, a selegiline transdermal system, is a monoamine...

Biz Journals: May 29 2009 11:38AM
Matching: emsam

Find similar documents

Dey L.P. to Market EMSAM(R) Skin Patch for Treatment of Major Depressive Disorder
PITTSBURGH, May 29 /PRNewswire-FirstCall/ -- Dey L.P., a subsidiary of Mylan Inc.

(Nasdaq: MYL), today announced that it has begun to market and distribute EMSAM(R) in the U.S.

EMSAM, a selegiline transdermal system, is a monoamine...

San Francisco Business Times: May 29 2009 11:37AM
Matching: emsam

Find similar documents

Dey L.P. to Market EMSAM(R) Skin Patch for Treatment of Major
Dey L.P., a subsidiary of Mylan Inc.

, today announced that it has begun to market and distribute EMSAM(R) in the U.S.

EMSAM, a selegiline transdermal system, is a monoamine oxidase inhibitor (MAOI), which was approved by the U.S....

PR Newswire via MSN Money: May 29 2009 11:37AM
Matching: emsam

Find similar documents

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.